PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 112 filers reported holding PULMONX CORP in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,278,050 | -21.2% | 994,971 | 0.0% | 5.54% | -5.1% |
| Q2 2023 | $13,044,070 | +17.3% | 994,971 | 0.0% | 5.83% | +18.5% |
| Q1 2023 | $11,123,776 | +32.6% | 994,971 | 0.0% | 4.92% | +23.2% |
| Q4 2022 | $8,387,606 | -76.6% | 994,971 | 0.0% | 3.99% | -44.1% |
| Q3 2021 | $35,799,000 | -18.4% | 994,971 | 0.0% | 7.14% | -11.6% |
| Q2 2021 | $43,898,000 | -3.5% | 994,971 | 0.0% | 8.08% | -13.6% |
| Q1 2021 | $45,510,000 | -48.5% | 994,971 | -30.0% | 9.36% | -34.5% |
| Q4 2020 | $88,294,000 | – | 1,421,386 | – | 14.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 815,019 | $37,279,000 | 40.66% |
| Yu Fan | 303,030 | $13,861,000 | 36.18% |
| ABG Innovation Capital Partners III GP Ltd | 833,333 | $38,117,000 | 18.73% |
| KPCB XIII Associates, LLC | 994,971 | $45,510,000 | 9.36% |
| Iron Triangle Partners LP | 600,000 | $27,444,000 | 3.49% |
| Miura Global Management | 405,000 | $18,525,000 | 3.31% |
| GREAT POINT PARTNERS LLC | 114,345 | $5,230,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 937,032 | $42,860,000 | 0.90% |
| ADAMS STREET PARTNERS LLC | 114,661 | $5,245,000 | 0.84% |
| RTW INVESTMENTS, LP | 1,129,600 | $51,668,000 | 0.81% |